Startup · $35m raised
Sydney, NSW
Every investor coverage indicates participated in a round Inventia Life Science raised.
| Investor | Rounds | Invested |
|---|---|---|
| Skip Capital | Series B | - |
| Blackbird Ventures | Series B | - |
Investors whose own portfolio pages list Inventia Life Science, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Main Sequence Ventures | its portfolio page ↗ |
| Tenmile | its portfolio page ↗ |
Companies Inventia Life Science acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Julio Ribeiro | CEO · Founder | Startup Daily (28 Nov 2022), Startup Daily (2 Jun 2022) |
Stories naming Inventia Life Science. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Concord Hospital researchers and Inventia Life Science developed 3D printed skin for burn patients, supported by a Medical Devices Fund grant the company previously received.
Inventia, a Sydney bioprinting startup, is expanding its facility with NSW Government Jobs Plus backing, creating 75-plus jobs; its $35 million Blackbird-led Series B from the prior year is also noted.
Rokt's Series E tops a week of Australian raises including Dovetail, Inventia, DiviPay, Atomi, 6clicks, Replica Studios and ProForm Foods, with SimPro's recent raise noted.
Also Techboard·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily